AI-generated summary
The authors studied 590 nm yellow LED light on human microvascular endothelial cells grown in the laboratory and in a pilot clinical study of melasma patients. In cells, they report reduced migration and tube formation and lower VEGF and SCF expression, linked to inhibition of the AKT/PI3K/mTOR pathway. They also report marked improvement in facial erythema and pigmentation after amber LED phototherapy in the pilot study.
- Who or what was studied
- Human microvascular endothelial cells (HMEC-1) in vitro and melasma patients in a pilot clinical study
- Wavelengths
- 590 nm
- Limits stated in the abstract
- The clinical component is described only as a pilot study, and the abstract does not report the number of patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Melasma is a common refractory acquired pigmentary skin disease that mainly affects middle-aged women. The pathogenesis of melasma is still uncertain, while abnormal vascular endothelial cells may play a role. We previously demonstrated the yellow light of light-emitting diodes (LED) could inhibit melanogenesis through the photobiomodulation (PBM) of melanocytes and keratinocytes. In the current study, we investigated the effect of 590 nm LED on the function of human microvascular endothelial cells (HMEC-1). We revealed 0-40 J/cm2 590 nm LED had no toxic effect on HMEC-1 in vitro. 590 nm LED irradiation significantly reduced cell migration, tube formation, as well as the expression of vascular endothelial growth factor (VEGF) and stem cell factor (SCF), a pro-melanogenic factor. Moreover, we illustrated that 590 nm LED inhibited the phosphorylation of the AKT/PI3K/mTOR signaling pathway, and the inhibitory effect on HMEC-1 could be partially reversed by insulin-like growth factor 1 (IGF-1), an AKT/PI3K/mTOR pathway agonist. Besides, we conducted a pilot clinical study and observed a marked improvement on facial erythema and pigmentation in melasma patients after amber LED phototherapy. Taken together, 590 nm LED inhibited HMEC-1 migration, tube formation and the secretion of VEGF and SCF, predominantly through the inhibition of the AKT/PI3K/mTOR pathway, which may serve as a novel therapeutic option for melasma.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 590 nm
- Energy density (fluence)
- 40 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Angiogenesis, Photobiomodulation, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.